Thousands of lives, statins and cholesterol -lowering drug combination can be recovered by the combination of working findings

According to new research, thousands of lives can be saved by combining statins with another cholesterol -lowering drug.

In patients with arteries, the biggest analysis to examine the best way to lower ‘bad’ cholesterol levels shows that they should be given a combination of a statin and another drug called ezimibe instead of statins.

Scientists say that combination therapy should be considered as ‘gold standard’ for patients who have already suffered a heart attack and can prevent thousands of deaths every year.

The researchers analyzed the findings of previous 14 studies, including 108,353 patients who were at risk of heart attack or stroke or already exposed to one of the other.

New studies have shown that the best way of bad cholesterol in patients with blocked arteries is to treat them with a combination of statin and oppression.

The study, published in the Mayo Clinic Proceedings magazine, showed that Ezimibe’s low-density lipoprotein cholesterol (LDL-C) levels were combined with a high dose statin, a decrease in a 19 percent decrease in the risk of death for any reason.

In addition, there was a 16 percent decrease in deaths caused by cardiovascular reasons compared to high doses of statins, and a large decrease of 18 percent and 17 percent in large adverse cardiovascular events or strokes, respectively.

Professor Peter Toth, a joint writer of the University of Illinois in the United States, said: ‘This study confirms that combined cholesterol lowering treatment should be taken into consideration immediately and that it should be gold standard for the treatment of very high -risk patients after an acute cardiovascular event.’